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Abstract
Background: Phagocytosis assays are traditionally performed in vitro using polymorphonuclear
leukocytes (PMNs) isolated from peripheral blood or the peritoneum and heat-killed, pre-
opsonized organisms. These assays may not adequately mimic the environment within the infected
lung. Our laboratory therefore has developed a flow cytometric in vivo phagocytosis assay that
enables quantification of PMN phagocytosis of viable bacteria within the lungs of rats. In these
studies, rats are injected transtracheally with lipopolysaccharide (LPS) to recruit PMNs to their
lungs. They are then infected with live 5(-and 6) carboxyfluorescein diacetate succinimidyl ester
(CFDA/SE) labeled type 3 Streptococcus pneumoniae. Bronchoalveolar lavage is performed and
resident alveolar macrophages and recruited PMNs are labeled with monoclonal antibodies specific
for surface epitopes on each cell type. Three color flow cytometry is utilized to identify the cell
types, quantify recruitment, and determine uptake of the labeled bacteria.
Results: The viability of the alveolar macrophages and PMNs isolated from the lavage fluid was
>95%. The values of the percentage of PMNs in the lavage fluid as well as the percentage of PMNs
associated with CFSE-labeled S. pneumoniae as measured through flow cytometry showed a high
degree of correlation with the results from manual counting of cytospin slides.
Conclusion: This assay is suitable for measuring bacterial uptake within the infected lung. It can
be adapted for use with other organisms and/or animal model systems.
Introduction
Phagocytosis and killing of pathogens by resident alveolar
macrophages and recruited polymorphonuclear leucko-
cytes (PMNs) is integral in clearing bacterial respiratory
tract infections. Because alveolar macrophages (AM) do
not efficiently phagocytose most strains of Streptococcus
pneumoniae (the pneumococcus), uptake and killing by
recruited PMNs is particularly important during pneumo-
coccal pneumonia [1]. For a number of years, our labora-
tory has been studying the effects of ethanol ingestion and
liver disease on pulmonary PMN function. We began with
traditional phagocytosis assays performed in vitro with
peripheral or peritoneal PMNs and heat-killed, pre-
opsonized organisms. Such assays are limited, however,
in that they cannot adequately mimic the conditions
present within the infected lung. Therefore, they may not
detect all host defects leading to reduced phagocytic
uptake of bacteria during pulmonary infections.
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One particular difficulty with the use of in vitro assays for
measurement of pneumococcal phagocytosis is that the
organisms are not taken up unless they are pre-opsonized
with serum containing active complement components,
even though the serum may contain high titers of specific
antipneumococcal antibodies [2]. This need for pre-
opsonization of the organisms makes it impossible to
examine certain underlying host immune defects such as
complement deficiencies. The serotype 3 pneumococcal
strain used in our studies (ATCC 6303) presents an addi-
tional unique difficulty when used in in vitro phagocytosis
assays because neither human nor rat PMNs phagocytose
this highly encapsulated S. pneumoniae strain in vitro [2-4].
The type 3 strain's ability to avoid phagocytosis in vitro has
been hypothesized to be the result of its large capsule that
precludes accessibility of its complement and immu-
noglobulin receptors [3].
Several years ago our laboratory developed an in vivo
phagocytosis assay that utilized flow cytometry and type 3
pneumococci labeled with Lucifer Yellow [2]. Although a
major improvement, this assay still was not physiologi-
cally relevant to the infection process because Lucifer Yel-
low is excluded by live bacteria. This necessitated heat-
killing of the bacteria, a process that can alter the patho-
gen's surface and impair the function of its anti-phago-
cytic capsule. To overcome this limitation of our original
in vivo assay, we now have created an in vivo phagocytosis
assay that utilizes live type 3 pneumococci and 3-color
flow cytometry. This assay allows for the measurement of
phagocytosis of live, non-opsonized S. pneumoniae within
the natural environment of the lung, enabling us to effec-
tively mimic the events that occur during an actual pneu-
mococcal infection. This manuscript describes and
validates our assay and demonstrates its potential for
adaptation to other microorganisms and animal models
of infection.
Results
Fluorescent labeling of bacteria and bacterial viability
To confirm that the S. pneumoniae organisms were ade-
quately labeled, flow cytometry was performed. Figure 1
shows that the bacteria effectively took up the CFDA/SE
and fluoresced brightly. To determine if our assay could
be utilized for the measurement of in vivo phagocytosis of
other bacterial organisms, we attempted to CFSE label
Escherichia coli and Staphylococcus aureus as well. Using the
protocol described in this paper, CFSE did not effectively
label E. coli organisms (data not shown). On the other
hand, S. aureus was labeled by CFSE, although the organ-
isms fluoresced at nearly a log lower intensity than S.
pneumoniae organisms (Figure 2). The CFSE staining pro-
tocol did not affect the viability of any of the organisms
(Table 1).
Flow cytometric analysis of BAL cells
To exclude autofluorescence of the PMN and macrophage
populations, a sample of BAL cells from a control animal
infected with live, but non-fluorescent S. pneumoniae was
used to calibrate the machine each day the assay was run.
Figure 3A shows the PMN population from one represent-
ative control animal. Figure 3B is a representative dot plot
of a test animal infected with CFSE-labeled pneumococci.
The percentage of RP-1-positive cells (PMNs, Figure 3A)
or 1C7-positive cells (macrophages, data not shown) that
had taken up the CFSE-labeled pneumococci was then
determined (Figure 3B).
Confocal microscopy of BAL cells
Confocal microscopy was performed to ensure that the
pneumococci were phagocytosed by the recruited PMNs,
not just adherent to the cell surface. Figure 4 shows the
confocal (4A) and phase overlay (4B) images of internal-
ized pneumococci.
Stability of CFSE labeling of pneumococci
To ensure that our results were not due to release of the
CFSE label during incubation of the pneumococci in the
rats' lungs and subsequent uptake of CFSE by the PMNs,
CFSE-labeled pneumococci were incubated at 37°C for 1
h in fresh BAL fluid. The bacteria were then removed by
centrifugation and the resulting supernatant was incu-
bated with BAL cells. Figure 5 shows an overlay image of
the lavage cells before (gray shading) and after (black
line) incubation with the supernatant showing a negligi-
ble shift in the cells' fluorescence.
Verification by light microscopy of PMN recruitment 
values
To validate our flow cytometric assay, we compared man-
ual counts of cytospin slides to the flow cytometric data.
Viability of the collected BAL cells was consistently >95%.
Cytospin preparations stained with Protocol Hema-3
were used to classify 200 cells in each sample based on
their morphological characteristics. The percentages of
macrophages and PMNs counted on the microscope
slides were quite similar to those determined by flow
cytometry. A comparison of the PMN values for ten repre-
sentative animals is shown in Table 2. For all 31 rats exam-
ined, the mean percent ± S.E.M. PMN recruitment
determined by flow cytometry was 70.9 ± 2.5, whereas the
mean determined by manual counts was 66.6 ± 1.9. The
correlation coefficient between the values measured by
the two methods was 0.488 (p < 0.006). The percentage of
macrophages present in each sample also correlated well
between the two methods of measurement with a correla-
tion coefficient of 0.578 (p < 0.0001).BMC Microbiology 2006, 6:61 http://www.biomedcentral.com/1471-2180/6/61
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Verification of phagocytosis values by light microscopy
Manual counts of cytospin slides prepared from each rat
also were used to verify the percentage of macrophage and
PMN phagocytosis measured by flow cytometry. A mini-
mum of 200 cells were counted in the light microscope to
quantify the percentage of each cell population that con-
Staining of S. pneumoniae with CFDA/SE Figure 1
Staining of S. pneumoniae with CFDA/SE. Forward vs. side scatter plots of Unlabeled (A) and CFDA/SE labeled (B) type 3 Strep-
tococcus pneumoniae are indistinguishable. Histograms of cell counts vs. CFSE staining (the fluorescent intracellular form of the 
dye), however, clearly demonstrate the shift in fluorescence between unlabeled (C) and CFDA/SE labeled (D) pneumococci.
AB
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tained internalized S. pneumoniae organisms. Flow cytom-
etry vs. light microscopy PMN phagocytosis values from
ten representative samples are shown in Table 3. For all 31
rats examined, the mean percent ± S.E.M. PMN phagocy-
tosis determined by flow cytometry was 16.1 ± 1.4,
whereas the mean determined by manual counts was 18.7
± 1.7. The correlation coefficient for the values deter-
mined by the two methods was 0.688 (p < 0.0002). Con-
Determination of percentage of PMNs with internalized bacteria Figure 3
Determination of percentage of PMNs with internalized bacteria. For each day of the assay, unlabeled S. pneumoniae were 
instilled into the lungs of a single rat. The PMNs collected from that rat by BAL [the RP-1 (PE) positive cells] were analyzed for 
autofluorescence in the CSFE channel and used to set a marker (shown in A) to delineate the PMNs in all other samples that 
had phagocytosed CFSE-labeled bacteria (shown in B).
A  Unlabeled Bacteria B  CFSE Labeled Bacteria
Staining of S. aureus with CFDA/SE Figure 2
Staining of S. aureus with CFDA/SE. Histograms of cell counts vs. CFSE staining, note the shift in fluorescence between unla-
beled (A) and CFDA/SE labeled (B) S. aureus.
A   Unlabeled S. aureus B  CFSE Labeled S. aureusBMC Microbiology 2006, 6:61 http://www.biomedcentral.com/1471-2180/6/61
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trary to the values for PMNs, the percentage of
phagocytosis values for macrophages did not correlate sig-
nificantly with a correlation coefficient of 0.0801 (p  =
.319) and values of 3.3 ± 0.4 determined by light micros-
copy and 7.3 ± 1.0 by flow cytometry.
Discussion
This manuscript describes an immunological assay to
measure PMN recruitment and phagocytosis of viable
type 3 Streptococcus pneumoniae within the lungs of rats
rather than the artificial environment used for in vitro
assays. Performing the experiment within the rats' lungs
allows the simultaneous measurement of recruitment and
phagocytosis and precludes the necessity for pre-opsoni-
zation of the organisms. One can therefore examine host
defects in opsonic capacity as well as phagocyte function.
The ability to utilize live bacteria is a major improvement
over our earlier in vivo assay [2] because it allows for quan-
tification of phagocytic uptake of organisms that are phys-
iologically relevant to those found during an actual
pulmonary infection.
One early difficulty in development of the assay was find-
ing a dye that could enter live S. pneumoniae and then
remain stable within the bacteria rather than leaking out
where it could be taken up by the phagocytes to give false
positive readings. The dye CFDA/SE fulfilled these
requirements; in its' nonfluorescent form it readily enters
live bacteria where the acetate groups are cleaved by
cytosolic esterases [5]. The CFSE molecule is stable within
Stability of CFSE Labeling of Pneumococci Figure 5
Stability of CFSE Labeling of Pneumococci. To ensure that 
CFSE did not leak out of labeled pneumococci when they 
were in the rats' lungs, CFSE labeled pneumococci were incu-
bated with fresh lavage fluid. After centrifugation to remove 
the bacteria the supernatant was incubated with lavage cells. 
Lavage cells before incubation with the supernatant (gray 
shading) and after (black line).
Phase contrast microscopy (A) was used to demonstrate the presence of the bacteria within the pulmonary cells and an over- lay technique (B) was used to show that the bacteria were internalized Figure 4
Phase contrast microscopy (A) was used to demonstrate the presence of the bacteria within the pulmonary cells and an over-
lay technique (B) was used to show that the bacteria were internalized.
ABBMC Microbiology 2006, 6:61 http://www.biomedcentral.com/1471-2180/6/61
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the bacterial cell, and does not leak out in appreciable
amounts, even when the pneumococci are allowed to
divide.
Our CFSE staining protocol effectively labeled S. aureus
organisms, but not E. coli. It may be that the gram negative
organism is either less permeable to the CFSE molecule or
able to pump it out of the cytoplasm (as is evidenced with
certain antibiotics). Therefore, the described in vivo
phagocytosis assay may only be useful for certain organ-
isms and not others. However, alternative fluorescent dyes
may be substituted for CFSE in our assay.
As expected, few alveolar macrophages were shown to
internalize pneumococci when examined by light micros-
copy. Unlike the PMN phagocytosis values, there was no
agreement or even correlation between the flow cytomet-
ric and light microscopy values for the alveolar macro-
phage population. The reason for the artificially high
phagocytosis values by flow cytometry is the intrinsically
high autofluorescence of rat macrophage populations [6].
This autofluorescence is at the same wavelength as the
CFSE fluorescence, thus precluding accurate measurement
of the macrophage phagocytosis. Pneumococci in general
and the type 3 strain in particular are known to resist
phagocytosis by macrophages [1]. For this reason we opti-
mized our assay for measuring recruitment and phagocy-
tosis of the PMN rather than the macrophage. In order to
utilize this assay for the measurement of macrophage
phagocytosis of other bacterial strains, it will be important
to make several adjustments to this protocol, which may
include using an alternate fluorochrome to label the
organism and/or a different anti-macrophage antibody.
The high degree of correlation between PMN phagocytosis
as determined by flow cytometry and the much more sub-
jective and labor intensive manual counting of cytospin
slides validates the flow cytometric method. As with all
phagocytosis assays, however, there is concern about the
ability to differentiate ingested organisms from those
bound to the outside of the phagocytes [7-9]. Tradition-
ally, differentiation of bound but not internalized organ-
isms has been accomplished through the addition of a
quenching agent such as ethidium bromide or trypan blue
that eliminates fluorescence of bound, but not internal-
ized organisms [7,8,10]. In our assay, using these agents
to quench externally bound organisms is not an option
because live S. pneumoniae exclude these quenching
agents. In addition, the monoclonal antibodies used to
identify the PMN and macrophage populations bind to
surface epitopes on the cells, and the addition of a
quenching agent may remove this fluorescence as well.
We therefore utilized confocal microscopy to confirm that
the organisms are located within the cell membrane rather
than bound to the surface of the cells.
Table 2: Comparison of PMN Recruitment Values Measured by the Two Methods in Ten Representative Samples
Percentage of PMNs in BALF
Rat Flow Cytometry Manual Counts
16 0 . 8 5 1 . 0
27 5 . 0 7 0 . 0
35 7 . 6 5 9 . 0
46 6 . 3 6 7 . 0
57 4 . 5 7 1 . 0
66 2 . 0 6 2 . 0
79 1 . 3 8 4 . 0
88 0 . 6 8 1 . 0
97 1 . 0 7 6 . 0
10 75.1 72.0
Table 1: Effect of CFSE on Bacterial Viability
Colony forming units/ml at O.D. of 1.0 at 540 nm
Bacterial Strains Unstained Stained
Streptococcus pneumoniae 7.0 × 108 7.9 × 108
Staphylococcus aureus 2.3 × 108 1.9 × 108
Escherichia coli 4.9 × 108 4.2 × 108BMC Microbiology 2006, 6:61 http://www.biomedcentral.com/1471-2180/6/61
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Conclusion
The novel in vivo phagocytosis assay described in this
manuscript provides a unique opportunity to "visualize"
what is occurring within the lungs during an actual infec-
tion and to measure several aspects of host defense against
pulmonary pathogens. Although the method has been
optimized for use with pneumococcal phagocytosis by
PMNs in rat lungs, the methods described can well be
adapted to measure pulmonary uptake of other microor-
ganisms in alternative animal models as well.
Methods
Animals
Male Sprague-Dawley rats (Charles River Laboratories,
Kingston, NY) weighing 350–400 g were used. All experi-
mental procedures described herein were approved by the
Animal Studies Subcommittee, both at Creighton Univer-
sity and the Omaha Veterans Affairs Medical Center.
Streptococcus pneumoniae growth and labeling 
conditions
The organism used for the phagocytosis assay was a type 3
S. pneumoniae (ATCC 6303; American Type Culture Col-
lection, Rockville, Maryland, USA) that was originally a
clinical isolate. It was stored at -80°C in Todd-Hewitt
Broth containing 10% glycerol. Before each experiment,
the bacteria were grown to mid-log phase in Todd-Hewitt
broth supplemented with 5% heat-inactivated rabbit
serum (Nieffengger Company, Woodland, CA). They were
collected by centrifugation at 10,000 × g for 10 minutes,
washed twice with phosphate buffered saline (PBS), and
resuspended in PBS to an optical density of 1.0 at 540 nm.
An aliquot of the suspension then was incubated at 37°C
for 30 min in the dark with an equal volume of a 2.0 μM
solution of 5(-and 6) carboxyfluorescein diacetate succin-
imidyl ester (CFDA/SE, Molecular Probes, Eugene, Ore-
gon), the non-fluorescent diacetate form of CFDA that
easily passes through cell membranes to label viable bac-
teria [5]. Once inside the organisms, the molecule is con-
verted to the fluorescent form known as CFSE [5(-and 6)
carboxyfluorescein succinimidyl ester].
After washing three times with PBS to remove excess dye,
the bacteria were once again resuspended in PBS to an
optical density of 2.5 at 540 nm (equivalent to 3 × 109 col-
ony forming units (cfu)/ml). To ensure that viability of
the pneumococci was not altered by CFSE labeling, aliq-
uots of a suspension of S. pneumoniae organisms (O.D. 1.0
at 540 nm) were serially diluted on sheep blood agar
plates before and after staining.
Flow cytometry of bacteria
Flow cytometry of bacteria was performed using standard
methods for bacterial analysis by flow cytometry. Briefly,
forward scatter, side scatter, and all fluorescence parame-
ters were collected in log mode. Instrument thresholding
was performed on either side and/or forward scatter sig-
nals. CFSE fluorescence was detected on the FACSCalibur
(Becton Dickinson, San Jose, CA) using a 530/30 band-
pass filter.
Labeling of other bacterial strains
Escherichia coli (ATCC25922) and Staphylococcus aureus
(ATCC25923) were grown overnight on blood agar plates,
and then resuspended in PBS to an optical density of 1.0
at 540 nm. An aliquot of the bacterial suspensions were
plated on sheep's blood agar plates to enumerate the col-
ony forming units before staining. Equal volumes of each
bacterial strain were incubated with CFSE as described
above for S. pneumoniae. The bacterial strains were then
washed twice with PBS and resuspended to an optical
density of 1.0 at 540 nm. An aliquot of the bacterial sus-
pensions were once again plated to determine the effect of
CFSE labeling on bacterial viability. Flow cytometry was
performed on fixed samples of the E. coli and S. aureus
organisms as described above.
Table 3: Comparison of PMN Phagocytosis Values Measured by the Two Methods in Ten Representative Samples
Percentage of PMNs Containing S. pneumoniae
Rat Flow Cytometry Manual Counts
12 9 . 6 2 7 . 0
22 0 . 1 1 8 . 0
32 8 . 5 3 8 . 0
41 7 . 9 2 7 . 0
51 4 . 3 1 4 . 0
61 2 . 6 9 . 0
7 2.3 5.0
8 7.1 8.0
9 8.4 8.0
10 15.4 19.0BMC Microbiology 2006, 6:61 http://www.biomedcentral.com/1471-2180/6/61
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Pulmonary PMN recruitment and bacterial instillation
PMNs were recruited to the rats' lungs by transtracheal
instillation of 20 μg Escherichia coli 026:B6 lipopolysac-
charide (Sigma, St. Louis, MO) in 0.2 mL PBS. This
amount of LPS has been shown to consistently increase
the percentage of PMN recoverable by bronchoalveolar
lavage (BAL) from <2% to >50% (2). Briefly, the rats were
anesthetized with isofluorane (Halocarbon Laboratories,
River Edge, New Jersey, USA), and blunt dissection to the
trachea was performed. A 20 gauge catheter was inserted
into the trachea, through which the LPS solution was
instilled into each rat's lungs. The skin then was closed
around the incision with a small metal clip. Five hours
after the LPS instillation, the clip was removed and the
rats were infected transtracheally through the same inci-
sion with 0.3 mL of the CFDA/SE labeled S. pneumoniae
(approximately 1 × 109 cfu/rat). This was followed by
instillation of 0.3 ml of air to simulate aspiration. This
was followed by instillation of 0.3 ml of air to simulate
aspiration. Plate counts of the bacterial suspension were
performed immediately before infection, to provide an
accurate measure of the organisms' viability.
Recovery of pulmonary cells
Exactly 15 minutes post-infection, each rat was eutha-
nized with an intraperitoneal injection of 75 mg/kg body
weight of pentobarbital (Nembutal, Abbot Laboratories,
Abbott Park, Illinois, USA). This short infection period
mimics that used in standard in vitro phagocytosis assays,
and prevents the division of fluorescent pneumococci
within the rats' lungs, which would result in a loss of flu-
orescence intensity. Pulmonary cells were collected by ex
vivo  BAL using a method described previously [11].
Briefly, the rats were exsanguinated by cardiac puncture
and their lungs were perfused with 30 ml of PBS to
remove contaminating peripheral blood cells. The lungs
and trachea then were removed en bloc, and pulmonary
cells were washed from the lungs by repeated instillation
of 10-ml aliquots of ice-cold Hanks' Balanced Salt Solu-
tion without Mg++  or Ca++  (HBSS, Gibco/Invitrogen,
Carlsbad, CA) through a catheter inserted into the original
incision and collected by dependent drainage until a total
of 50 ml of lavage fluid was obtained. BAL cells collected
from the lavage fluid were washed twice with HBSS using
differential centrifugation (180 × g for 8 minutes) to
remove unassociated bacteria. Erythrocytes were lysed
hypotonically by the addition of 10 ml of deionized water
followed in 10 seconds by an equal volume of double
strength PBS. The remaining cells were centrifuged and
resuspended in PBS containing 4% heat-inactivated fetal
calf serum (PBS-FCS), counted on a hemacytometer, and
adjusted to a concentration of 2 × 107 cells/ml. Viability of
the cells was assessed through trypan blue exclusion, and
aliquots of each sample were reserved for cytocentrifuga-
tion and microscopic analysis.
Flow cytometry
For flow cytometric analysis, 50 μL of cell suspension
from each BAL sample (1 × 106 cells) were stained for 30
minutes in the dark at 4°C in 96-well U-bottom micro-
plates with 50 μL of a monoclonal antibody cocktail con-
taining the phycoerythrin (PE)-conjugated anti-rat
granulocyte antibody RP-1 (Pharmingen, San Diego, CA)
and the biotinylated anti-rat monocyte antibody 1C7
(Pharmingen). The cells then were washed three times
with PBS-FCS and incubated for an additional 5 minutes
in the dark at 4°C with allophycocyanin (APC) -conju-
gated Streptavidin (Pharmingen) to stain the monocytes.
After three more washes in PBS-FCS, the BAL cells were
resuspended in PBS containing 1% formalin. Negative
control samples for each rat consisted of unstained BAL
cells and BAL cells stained only with APC-Streptavidin.
Three color flow cytometric analysis was performed using
a FACSCalibur flow cytometer with dual laser excitation
(488 nm and 633 nm). A single sample of BAL cells col-
lected from a rat infected with nonfluorescent type 3 S.
pneumoniae organisms was included each day to exclude
autofluorescence of the RP-1 (PE) positive PMN and 1C7
(APC) positive macrophages populations in the CFSE
channel. We also used a gate to identify single PMNs and
remove debris, non-cellular and on-axis events. The per-
centage of RP-1 or 1C7- positive cells then was counted as
the percentage of PMNs or macrophages associated with
bacteria.
Based on scatter characteristics that included PMNs and
macrophages, a minimum of 20,000 cells from each sam-
ple were analyzed. The frequency of RP-1 positive PMNs
and 1C7-positive macrophages, as well as the percentage
of each cell type containing associated fluorescent bacteria
was determined for each sample using the CellQuest Pro
software (Becton Dickinson, San Jose, CA).
Microscopic analysis
Cytospin slides (Cytospin 2, Shandon, Cheshire, UK) pre-
pared from each BAL sample analyzed by flow cytometry
were stained with Protocol Hema-3 (Fisher Diagnostics,
Middletown, Virginia, USA), and 200 cells from each sam-
ple were counted manually in a Nikon Labopho-2
(Melville, NY) to verify the percentage of PMNs and mac-
rophages in the BAL cell population and the percentage of
each cell type that had phagocytosed S. pneumoniae. For
confocal microscopy, unstained cytospin slides were pre-
pared of cell samples after they had been treated with the
fluorochrome-labeled RP-1 and 1C7 antibodies. The
slides were examined with a Zeiss LSM 410 confocal laser
scanning microscope with an Argon/Krypton (488 nm/
568 nm/647 nm) laser (Goettinger, Germany) to demon-
strate that cell-associated bacteria were internalized.Publish with BioMed Central    and   every 
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Analysis of CFSE leakage during pneumococcal division
To determine if the CFSE label would leak out of the pneu-
mococci during bacterial cell division, a 300 μl aliquot of
the stained organisms was incubated with an equal vol-
ume of fresh rat lavage fluid at 37°C for 1 hour, to mimic
the actual infection process. The pneumococci were then
removed by centrifugation at 10,000 × g for 10 minutes.
The resulting supernatant was incubated with 1 × 107 BAL
cells from the same animal for 30 minutes at 37°C. The
BAL cells were washed, fixed and flow cytometry was per-
formed to detect any shift in fluorescence that could be
attributable to leakage of CFSE during incubation in the
lavage fluid and subsequent staining of the lavage cells.
Statistical analyses
Normally distributed recruitment and phagocytosis data
from microscopic and flow cytometric analyses were com-
pared by Student's t-test (SigmaStat 3.0, Leesburg, VA).
Non-parametric data were analyzed by the Mann-Whitney
rank sum test (SigmaStat 3.0). Agreement between the
flow cytometric and manual methods of measurement
was quantified using Spearman's rank correlation coeffi-
cient (SigmaStat 3.0). A p < 0.05 was considered signifi-
cant for all comparisons.
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